GSK tech exec joins Institute of Cancer Research
June 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information …
Catalyst Pharma sues FDA after agency approves Jacobus’ LEMS drug
June 13, 2019Business Services, Manufacturing and Production FDA, Jacobus, catalyst, firdapse, pharma, ruzurgi
Florida firm Catalyst Pharmaceuticals is suing the FDA after the agency approved a rival’s drug. The lawsuit alleges the approval …
FDA offer priority review for Genentech’s Rituxan in children
June 13, 2019Research and Development
The FDA will offer priority review to Genentech’s supplemental biologics-license application (sBLA) application for Rituxan for children with two rare …
Sobi acquire Novimmune in deal worth more than £400 million
June 13, 2019Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma
Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million. …
J&J and Colgate pay $4.8 million each to woman in California
June 13, 2019Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc
A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a …
AstraZeneca spends more than twice as much as expected on new HQ
June 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma
AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …
Fewer opioids prescribed in states with medical marijuana, research shows
June 12, 2019Research and Development Marijuana, medicinal cannabis, opioids, pharma
Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …
J&J ‘worse’ than Purdue Pharma expert witness says
June 12, 2019Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra
The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …
Novo Nordisk’s oral diabetes drug safe and effective
June 12, 2019Research and Development GLP-1, Novo Nordisk, diabetes, pharma, samgalutide
Novo Nordisk’s oral diabetes drug semaglutide is safe for those at high risk of cardiovascular complications, according to the results …
First case of Ebola recorded in Uganda
June 12, 2019Research and Development
Ebola has spread to Uganda, according to the WHO. A five year old boy has been infected with the Ebola …
MPs discuss breaking Vertex’s IP rights to bring Orkambi to UK
June 11, 2019Research and Development Orkambi, Vertex, access, house of commons, pharma, pricing
MPs yesterday discussed circumventing Vertex’s patent on cystic fibrosis medicine Orkambi (Lumacaftor/ivacaftor) as a means of breaking the deadlock and …
AstraZeneca’s Phase 3 Farxiga data impresses in type 2 diabetes
June 11, 2019Manufacturing and Production, Research and Development AstraZeneca, diabetes, farxiga, pharma, type 2 diabetes
AstraZeneca has presented new Phase 3 data at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco on …
Eli Lilly’s heart drug underwhelms with REWIND trial
June 11, 2019Manufacturing and Production Eli Lilly, Trulicity, pharma
Eli Lilly’s Trulicity (dulaglutide) reduced major cardiovascular events (MACE) by 12% versus placebo in adults with type 2 diabetes, according …
Three workers killed by explosion at pharma factory in India
June 11, 2019Manufacturing and Production China, India, explosion, manufacturing, pharma
Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …
Roche scores FDA approval for Polivy combo in diffuse large B-cell lymphoma
June 11, 2019Manufacturing and Production, Sales and Marketing Polivy, Roche, lymphoma, pharma
Roche is celebrating the decision taken by the FDA to approve its anti-CD79b antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) in combination …
Insys Therapeutics files for bankruptcy
June 11, 2019Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma
Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …
Novartis Pharma head to become new Sanofi CEO
June 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, appointment, olivier brandicourt
French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
MSD scoops up biopharma firm Tilos for $773 million
June 10, 2019Sales and Marketing MSD, Tilos Therapeutics, acquisition, pharma
US-based firm MSD has announced it intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the …
Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels
June 10, 2019Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes
Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …
Novo’s oral semaglutide tops Jardiance and Victoza in two type 2 diabetes trials
June 10, 2019Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has taken the opportunity at the American Diabetes Association (ADA) 79th Scientific Sessions to pull back the curtain …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
